Stay updated on TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new version (55) was added, updating the Study Status and Contacts/Locations for NCT04919512.
    Difference
    0.2%
    Check dated 2025-12-08T19:42:17.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.2 where it previously displayed Revision: v3.3.1.
    Difference
    0.1%
    Check dated 2025-12-01T16:41:07.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Footer revision updated from v3.2.0 to v3.3.1 with no changes to study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:43:44.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Version history shows a new 'Study Status' entry (version 54) added on 2025-11-07, and a government funding outage notice from 2025-10-10 was removed. These are administrative UI/content changes and do not alter the underlying study data.
    Difference
    0.6%
    Check dated 2025-11-17T06:22:01.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The new screenshot shows additional entries in the Study Record History list, extending the history of submitted versions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T00:59:10.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added current dates and study status (more up-to-date, time-sensitive content); removed an older date. Core meaning remains, with emphasis shifting to recent temporal context.
    Difference
    0.8%
    Check dated 2025-10-12T14:14:09.000Z thumbnail image

Stay in the know with updates to TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.